Dr Louise Hayes Dr Richard McNally Professor Janet Berrington Professor Nicholas Embleton
| Formula with large, milk phospholipid-coated lipid droplets in late-moderate preterm infants: a double-blind RCT | 2024 |
|
Dr Jemma Cleminson Dr Julian Thomas Professor Christopher Stewart Dr David Campbell Professor Andrew Gennery et al. | Gut microbiota and intestinal rehabilitation: A prospective childhood cohort longitudinal study of short bowel syndrome (the MIRACLS study): Study protocol | 2024 |
|
Dr Andrea Masi Dr Lauren Beck Dr John Perry Dr Claire Granger Dr Greg Young et al. | Human milk microbiota, oligosaccharide profiles, and infant gut microbiome in preterm infants diagnosed with necrotizing enterocolitis | 2024 |
|
Dr Lauren Beck Professor Janet Berrington Professor Christopher Stewart
| Impact of probiotics on gut microbiome of extremely preterm or extremely low birthweight infants | 2024 |
|
Professor Janet Berrington
| Probiotics for preterms: sharing complex decision-making | 2024 |
|
Dr Louise Hayes Dr Richard McNally Professor Janet Berrington Professor Nicholas Embleton
| Early infancy growth, body composition and type of feeding in late and moderate preterms | 2023 |
|
Professor Nicholas Embleton Dr Tom Sproat Andrea Masi Lauren Beck Professor Christopher Stewart et al. | Effect of an Exclusive Human Milk Diet on the Gut Microbiome in Preterm Infants: A Randomized Clinical Trial | 2023 |
|
Dr Claire Granger Professor Nicholas Embleton Dr Robert Tinnion Professor Janet Berrington
| Impact of Transfer for Surgical Management of Preterm Necrotising Enterocolitis or Focal Intestinal Perforation | 2023 |
|
Professor Janet Berrington Professor Nicholas Embleton
| Necrotising enterocolitis, focal intestinal perforation or something else: how best to proceed | 2023 |
|
Chris Price Professor Janet Berrington Professor Christopher Stewart
| Particular genomic and virulence traits associated with preterm infant-derived toxigenic Clostridium perfringens strains | 2023 |
|
Professor Nicholas Embleton Professor Janet Berrington
| Probiotics for preterm infants and the recent FDA alert in the USA | 2023 |
|
Professor Christopher Stewart Dr Simon Bridge Dr Claire Granger Professor Janet Berrington Professor Nicholas Embleton et al. | The core phageome and its interrelationship with preterm human milk lipids | 2023 |
|
Sinéad Ahearn-Ford Professor Janet Berrington Professor Christopher Stewart
| Development of the gut microbiome in early life | 2022 |
|
Professor Janet Berrington Professor Nicholas Embleton
| Discriminating necrotising enterocolitis and focal intestinal perforation | 2022 |
|
Andrea Masi Professor Chris Lamb Dr Simon Cockell Dr Jonathan Coxhead Professor Nicholas Embleton et al. | Distinct gene expression profiles between human preterm- and adult-derived intestinal organoids exposed to Enterococcus faecalis: A pilot study | 2022 |
|
Professor Janet Berrington
| Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants-study protocol for the AZTEC-FU study | 2022 |
|
Professor Christopher Stewart Professor Janet Berrington Professor Nicholas Embleton
| Integrating longitudinal clinical and microbiome data to predict growth faltering in preterm infants | 2022 |
|
Dr Rebecca Naples Professor Judith Rankin Professor Janet Berrington Dr Sundeep Harigopal
| Life-threatening bronchopulmonary dysplasia: A British Paediatric Surveillance Unit Study | 2022 |
|
Professor Janet Berrington Emeritus Professor John Kirby Lauren Beck Professor Chris Lamb Professor Christopher Stewart et al. | Mechanisms affecting the gut of preterm infants in enteral feeding trials: a nested cohort within a randomised controlled trial of lactoferrin | 2022 |
|
Professor Nicholas Embleton Professor Janet Berrington
| Milk-Based Bionutrient Trials to Improve Outcomes in Preterm Infants: Challenges and Opportunities | 2022 |
|
Dr Claire Granger Professor Chris Lamb Professor Nicholas Embleton Lauren Beck Andrea Masi et al. | sIgA in preterm infants: determination of normal values in breast milk and stool | 2022 |
|
Professor Janet Berrington
| Starting and Increasing Feeds, Milk Tolerance and Monitoring of Gut Health in Significantly Preterm Infants | 2022 |
|
Lauren Beck Andrea Masi Professor Chris Lamb Rachel Smith Dr Jonathan Coxhead et al. | Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants | 2022 |
|
Professor Janet Berrington Dr Richard McNally Professor Christopher Stewart Professor Nicholas Embleton
| An observational cohort study and nested randomised controlled trial on nutrition and growth outcomes in moderate and late preterm infants (FLAMINGO). | 2021 |
|
Andrea Masi Professor Nicholas Embleton Professor Chris Lamb Grace Young Dr Claire Granger et al. | Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis | 2021 |
|
Dr Claire Granger Professor Nicholas Embleton Dr Jeremy Palmer Professor Chris Lamb Professor Janet Berrington et al. | Maternal breastmilk, infant gut microbiome and the impact on preterm infant health | 2021 |
|
Professor Christopher Stewart Professor Janet Berrington Professor Nicholas Embleton
| The stool volatile metabolome of pre-term babies | 2021 |
|
Dr Darren Smith Professor Janet Berrington Professor Nicholas Embleton Dr Clare Lanyon
| Acquisition and Development of the Extremely Preterm Infant Microbiota Across Multiple Anatomical Sites | 2020 |
|
Professor Nicholas Embleton Professor Janet Berrington
| Clinical trials of lactoferrin in the newborn: Effects on infection and the gut microbiome | 2020 |
|
Professor Janet Berrington Professor Nicholas Embleton
| Economic evaluation alongside the Speed of Increasing milk Feeds Trial (SIFT) | 2020 |
|
Dr Lucy Crouch Dr Arnaud Basle Professor Chris Lamb Professor Christopher Stewart Kate Cooke et al. | Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown | 2020 |
|
Dr Sara Johansson Fernstad Dr Alexander Macquisten Professor Janet Berrington Professor Nicholas Embleton Professor Christopher Stewart et al. | Quality Metrics to Guide Visual Analysis of High Dimensional Genomics Data | 2020 |
|
Professor Janet Berrington
| Addressing safety concerns of probiotic use in preterm babies | 2019 |
|
Professor Janet Berrington Dr Stefan Zalewski
| The future of probiotics in the preterm infant | 2019 |
|
Dr Ben Shillitoe Professor Janet Berrington Dr Naveen Athiraman
| Congenital pleural effusions: 15 years single-centre experience from North-East England | 2018 |
|
Dr Darren Smith Professor Nicholas Embleton Professor Janet Berrington Dr Ed Schwalbe Dr Clare Lanyon et al. | Response: Commentary: Reducing Viability Bias in Analysis of Gut Microbiota in Preterm Infants at Risk of NEC and Sepsis | 2018 |
|
Professor Janet Berrington Professor Nicholas Embleton Dr Ruppa Geethanath Dr Mithilesh Lal
| Retinopathy of prematurity screening at ≥30 weeks: urinary NTpro-BNP performance | 2018 |
|
Dr Stefan Zalewski Professor Christopher Stewart Professor Nicholas Embleton Professor Janet Berrington
| Brief guide to the analysis, interpretation, and presentation of microbiota data | 2017 |
|
Professor Christopher Stewart Professor Nicholas Embleton Professor Janet Berrington
| Cesarean or vaginal birth does not impact the longitudinal development of the gut microbiome in a cohort of exclusively preterm infants | 2017 |
|
Professor Nicholas Embleton Professor Janet Berrington
| Elevated levels of circulating cell-free DNA and neutrophil proteins are associated with neonatal sepsis and necrotizing enterocolitis in immature mice, pigs and infants | 2017 |
|
Professor Christopher Stewart Professor Nicholas Embleton Dr Thomas Skeath Dr John Perry Professor Janet Berrington et al. | Longitudinal development of the gut microbiome and metabolome in preterm neonates with late onset sepsis and healthy controls | 2017 |
|
Professor Nicholas Embleton Professor Janet Berrington Emeritus Professor John Kirby Professor Chris Lamb Professor Stephen Rushton et al. | Mechanisms Affecting the Gut of Preterm Infants in Enteral Feeding Trials | 2017 |
|
Dr Darren Smith Professor Nicholas Embleton Professor Janet Berrington Dr Ed Schwalbe Dr Clare Lanyon et al. | Reducing Viability Bias in Analysis of Gut Microbiota in Preterm Infants at Risk of NEC and Sepsis | 2017 |
|
Dr Thomas Skeath Professor Nicholas Embleton Professor Janet Berrington
| Circulating neutrophil extracellular trap components are associated with sepsis and necrotizing enterocolitis in newborn, immature infants, pigs and mice | 2016 |
|
Dr Tom Skeath Professor Christopher Stewart Dr Sheila Waugh Professor Nicholas Embleton Professor Janet Berrington et al. | Cytomegalovirus and other common enteric viruses are not commonly associated with Necrotizing Enterocolitis | 2016 |
|
Professor Christopher Stewart Dr Achim Treumann Professor Nicholas Embleton Professor Janet Berrington
| Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis | 2016 |
|
Professor Nicholas Embleton Dr Stefan Zalewski Professor Janet Berrington
| Probiotics for prevention of necrotizing enterocolitis and sepsis in preterm infants | 2016 |
|
Professor Janet Berrington Dr Martin Ward Platt
| Recent advances in the management of infants born <1000 g. | 2016 |
|
Dr John Perry Professor Nicholas Embleton Professor Janet Berrington Professor Christopher Stewart
| Routine use of probiotics in preterm infants: longitudinal impact on the microbiome and metabolome | 2016 |
|
Dr Tom Skeath Dr John Perry Professor Nicholas Embleton Professor Janet Berrington Professor Christopher Stewart et al. | Stool bacterial load in preterm infants with necrotising enterocolitis | 2016 |
|
Professor Christopher Stewart Professor Nicholas Embleton Dr Thomas Skeath Dr John Perry Professor Janet Berrington et al. | Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease | 2016 |
|
Dr Eleri Williams Professor Janet Berrington
| Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK | 2015 |
|
Dr Eleri Williams Jo Gray Professor Nicholas Embleton Professor Janet Berrington
| First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection | 2015 |
|
Professor Christopher Stewart Dr Tom Skeath Dr Sara Johansson Fernstad Dr John Perry Professor Janet Berrington et al. | Preterm gut microbiota and metabolome following discharge from intensive care | 2015 |
|
Dr Eleri Williams Professor Janet Berrington Professor Nicholas Embleton Dr Peter James
| Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss | 2014 |
|
Professor Janet Berrington Professor Christopher Stewart Professor Nicholas Embleton
| Proportionate Reduction in Uncertainty of Late Onset Infection in Pre-term Infants by Neutrophil CD64 Measurement | 2014 |
|
Professor Janet Berrington Professor Nicholas Embleton
| The Nasopharyngeal Microbiota: An Important Window of Opportunity | 2014 |
|
Professor Janet Berrington Professor Christopher Stewart Professor Nicholas Embleton
| The neonatal bowel microbiome in health and infection | 2014 |
|
Professor Christopher Stewart Dr Clare Lanyon Dr John Perry Professor Nicholas Embleton Professor Janet Berrington et al. | Bacterial and fungal viability in the preterm gut: NEC and sepsis | 2013 |
|
Dr Eleri Williams Professor Janet Berrington
| Clinically targeted screening for congenital CMV - potential for integration into the National Hearing Screening Programme | 2013 |
|
Professor Christopher Stewart Dr Clare Lanyon Dr John Perry Professor Nicholas Embleton Professor Janet Berrington et al. | Development of the Preterm Gut Microbiome in Twins at Risk of Necrotising Enterocolitis and Sepsis | 2013 |
|
Professor Janet Berrington Professor Christopher Stewart Professor Nicholas Embleton
| Gut microbiota in preterm infants: assessment and relevance to health and disease | 2013 |
|
Professor Nicholas Embleton Professor Janet Berrington Professor Christopher Stewart
| Lactoferrin: Antimicrobial activity and therapeutic potential | 2013 |
|
Professor Nicholas Embleton Dr Stephen Turner Professor Janet Berrington
| Successful blood salvaging from preterm infants: maximizing opportunities, minimizing interventions | 2013 |
|
Professor Nicholas Embleton Mary Bythell Professor Janet Berrington
| The changing profile of infant mortality from bacterial, viral and fungal infection over two decades | 2013 |
|
Dr Eleri Williams Professor Nicholas Embleton Mary Bythell Professor Janet Berrington
| Viral Infections: Contributions to Late Fetal Death, Stillbirth, and Infant Death | 2013 |
|
Professor Janet Berrington Mary Bythell Dr Christopher Wright Professor Nicholas Embleton
| Deaths in Preterm Infants: Changing Pathology Over 2 Decades | 2012 |
|
Professor Christopher Stewart Dr Clare Lanyon Dr John Perry Professor Nicholas Embleton Professor Janet Berrington et al. | The preterm gut microbiota: changes associated with necrotizing enterocolitis and infection | 2012 |
|
Dr Eve Atkinson Ayad Shafiq Dr Clark Clark Professor Janet Berrington
| Two high pressure conundrums and a possible congenital link | 2011 |
|
Professor Nicholas Embleton Professor Janet Berrington
| Giving vancomycin as a continuous infusion | 2009 |
|
Professor Janet Berrington Dr Alan Fenton
| Avidity of Haemophilus influenzae type b antibody in UK infants | 2007 |
|
Professor Janet Berrington Dr Alan Fenton Professor Andrew Cant Dr Gavin Spickett Dr Marilyn O'Keeffe et al. | Reduced anti-PRP antibody response to Hib immunisation in preterm (<32 weeks) UK infants who received inactivated polio (eIPV) | 2007 |
|
Professor Janet Berrington Professor Andrew Cant Professor John Matthews Dr Marilyn O'Keeffe Dr Gavin Spickett et al. | Haemophilus influenzae type b immunization in infants in the United Kingdom: Effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose | 2006 |
|
Professor Janet Berrington Dr Alan Fenton
| Interpreting immunogenicity data in UK studies | 2005 |
|
Professor Janet Berrington Dr Alan Fenton Professor Andrew Cant Dr Gavin Spickett
| Lymphocyte subsets in term and significantly preterm UK infants in the first year of life analysed by single platform flow cytometry | 2005 |
|
Dr Alan Fenton Professor Janet Berrington Dr Gavin Spickett Professor Andrew Cant Dr Marilyn O'Keeffe et al. | Haemaphilus influenzaeType b (Hib) antibody response following pragmatic UK immunisation with mixed regimes of acellular and/or whole cell DTPHib combination vaccines | 2004 |
|
Professor Janet Berrington Dr Alan Fenton
| Immunization responses in preterm infants who receive postnatal steroid treatment | 2004 |
|
Dr David Milligan Professor Janet Berrington
| Probable adverse reaction to a pharmaceutical excipient | 2004 |
|
Professor Janet Berrington Dr Alan Fenton Dr Gavin Spickett Professor Andrew Cant
| Haemophilus influenzae type b (Hib) antibody response in significantly preterm UK infants | 2003 |
|
Professor Janet Berrington Dr Terence Flood Dr Mario Abinun Dr Angela Galloway Professor Andrew Cant et al. | Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency | 2000 |
|